Published in Eur J Neurosci on January 25, 2010
Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses. J Neurosci (2013) 1.06
Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys. J Comp Neurol (2011) 0.97
Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? Neuroscience (2013) 0.96
Striatal shape in Parkinson's disease. Neurobiol Aging (2013) 0.88
Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease. Front Syst Neurosci (2011) 0.85
The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias. Brain Res Bull (2011) 0.82
Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons. EMBO Mol Med (2014) 0.82
Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease. PLoS One (2013) 0.78
Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease. J Neurosci (2015) 0.77
Treating Parkinson's disease: preserve the spines! (Commentary on Soderstrom et al.). Eur J Neurosci (2010) 0.77
Morphological changes of glutamatergic synapses in animal models of Parkinson's disease. Front Neuroanat (2015) 0.76
Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum. Basal Ganglia (2012) 0.76
Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link? Front Cell Neurosci (2016) 0.75
Repairing the Aged Parkinsonian Striatum: Lessons from the Lab and Clinic. J Clin Cell Immunol (2016) 0.75
Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med (2001) 9.51
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21
Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology (2004) 6.08
CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology (2000) 5.63
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med (1995) 3.64
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci (2002) 2.01
Behavioral tests for preclinical intervention assessment. NeuroRx (2006) 1.75
Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Can J Neurol Sci (1984) 1.57
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology (2005) 1.56
Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience (2005) 1.51
Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci (2005) 1.51
Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. Mol Pharmacol (2004) 1.46
Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res (1988) 1.28
Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol Dis (2007) 1.26
The spectrum of levodopa-induced dyskinesias. Ann Neurol (2000) 1.17
Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant (2000) 1.15
Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience (2007) 1.10
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol Psychiatry (2008) 1.07
Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol Dis (2005) 1.01
Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats. Mov Disord (2003) 0.99
Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias. J Neurosci (2000) 0.98
Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J Neurosci (1985) 0.98
Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J Comp Neurol (1985) 0.98
Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway. J Comp Neurol (2006) 0.97
Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci (2001) 0.96
Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA. Brain Res (2005) 0.95
The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors. Neurobiol Dis (2008) 0.95
Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease. J Neural Transm Suppl (2006) 0.88
The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease. J Neurosci (2007) 0.88
Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons. J Neurosci (2009) 0.87
Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD. Parkinsonism Relat Disord (2008) 0.86
Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals. Exp Brain Res (1998) 0.86
Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats. Neuroreport (1997) 0.84
Recognition and management of Parkinson's disease during the premotor (prodromal) phase. Expert Rev Neurother (2009) 0.82
The detrimental effect of levodopa on behavioral efficacy of fetal dopamine neuron grafts in rats is reversible following prolonged withdrawal of chronic dosing. Brain Res (1995) 0.82
Nimodipine enhances growth and vascularization of neural grafts. Exp Neurol (1989) 0.82
A global view of Parkinson's disease pathogenesis: implications for natural history and neuroprotection. Parkinsonism Relat Disord (2009) 0.81
Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis. Clin Neuropharmacol (1993) 0.81
Levodopa-induced dyskinesia in the normal rhesus monkey. Mt Sinai J Med (1972) 0.78
Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ (2004) 4.69
The role of alpha-synuclein in Parkinson's disease: insights from animal models. Nat Rev Neurosci (2003) 1.92
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J (2011) 1.34
Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat. Neurobiol Dis (2011) 1.21
Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability. J Comp Neurol (2007) 1.11
Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Ann Neurol (2006) 1.08
Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses. J Neurosci (2013) 1.06
Transplantation of subventricular zone neural precursors induces an endogenous precursor cell response in a rat model of Parkinson's disease. J Comp Neurol (2009) 1.01
Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol Dis (2005) 1.01
Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats. Mov Disord (2003) 0.99
Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. PLoS One (2013) 0.99
Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex. J Parkinsons Dis (2011) 0.97
Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease. Brain Res (2007) 0.95
Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons. J Neurochem (2002) 0.91
Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease. Brain Res (2005) 0.91
Primate models of Parkinson's disease. Exp Neurol (2003) 0.91
Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. J Comp Neurol (2003) 0.90
Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model. Mol Ther (2011) 0.88
Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats. J Comp Neurol (2009) 0.87
Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys. Neurobiol Aging (2008) 0.86
Neural repair strategies for Parkinson's disease: insights from primate models. Cell Transplant (2006) 0.86
Reassessment of caspase inhibition to augment grafted dopamine neuron survival. Cell Transplant (2004) 0.85
Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain. J Neurosci Methods (2013) 0.85
Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. J Comp Neurol (2002) 0.84
Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells. Exp Neurol (2003) 0.84
Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease. Mov Disord (2012) 0.83
Cellular repair in the parkinsonian nonhuman primate brain. Rejuvenation Res (2010) 0.83
Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons. J Neurosci Methods (2007) 0.82
Endogenous neural precursors influence grafted neural stem cells and contribute to neuroprotection in the parkinsonian rat. Eur J Neurosci (2012) 0.82
A synergistic approach for neural repair: cell transplantation and induction of endogenous precursor cell activity. Neuropharmacology (2009) 0.82
3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture. Neuropharmacology (2008) 0.80
Cellular models to study dopaminergic injury responses. Ann N Y Acad Sci (2003) 0.80
Agonists of the tissue-protective erythropoietin receptor in the treatment of Parkinson's disease. Curr Top Med Chem (2015) 0.80
Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems. J Neurosci Res (2005) 0.79
Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival. Brain Res (2006) 0.77
Dietary supplementation with blueberry extract improves survival of transplanted dopamine neurons. Nutr Neurosci (2007) 0.76
An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality. Exp Neurol (2004) 0.76
A potential compensatory role for endogenous striatal tyrosine hydroxylase-positive neurons in a nonhuman primate model of Parkinson's disease. Cell Transplant (2015) 0.75
TRANSPLANTATION OF NEURAL TISSUE INTO THE SPINAL CORD. Cell Transplant (1995) 0.75